YU48399A - Supstituisani izohinolini kao neuromuskularni blokatori ultrakratkog delovanja - Google Patents
Supstituisani izohinolini kao neuromuskularni blokatori ultrakratkog delovanjaInfo
- Publication number
- YU48399A YU48399A YU48399A YU48399A YU48399A YU 48399 A YU48399 A YU 48399A YU 48399 A YU48399 A YU 48399A YU 48399 A YU48399 A YU 48399A YU 48399 A YU48399 A YU 48399A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- short acting
- ultra short
- neuromuscular blockers
- acting neuromuscular
- substituted isoquinolines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
- C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Surgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Opisana su sredstva za neuromuskularno blokiranje ultrakratkog delovanja formule (I) koja su korisna kao sredstva za otpuštanje skeletnih mišića tokom urgentnih procedura unošenja cevčica u dušnik, rutinskih hirurških zahvata i posleoperativnih stanja, pri čemu X je halogen, h je od 1 do 2, Y je vodonik ili metoksi, Z1 i Z2 su metil, W1 i W2 su ugljenik a A je jedan farmaceutski prihvatljiv anjon.[Ultrashort acting neuromuscular blocking agents of Formula (I) which are useful as skeletal muscle relaxants during emergency intubation procedures, routine surgery and post-operative settings are disclosed, wherein: X is halogen; h is from 1 to 2; Y is hydrogen or methoxy; Z1 and Z2 are methyl; W1 and W2 are carbon; and A is a pharmaceutically acceptable anion.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9706117.0A GB9706117D0 (en) | 1997-03-25 | 1997-03-25 | Ultra-short acting neuromuscular blockers |
| GBGB9724987.4A GB9724987D0 (en) | 1997-11-27 | 1997-11-27 | Ultra-short acting neuromuscular blockers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU48399A true YU48399A (sh) | 2002-06-19 |
| RS49869B RS49869B (sr) | 2008-08-07 |
Family
ID=26311255
Country Status (37)
| Country | Link |
|---|---|
| US (2) | US6177445B1 (sh) |
| EP (4) | EP1526130A1 (sh) |
| JP (3) | JP4112015B2 (sh) |
| KR (2) | KR100554601B1 (sh) |
| CN (1) | CN1203061C (sh) |
| AP (1) | AP1797A (sh) |
| AR (1) | AR012156A1 (sh) |
| AT (3) | ATE254107T1 (sh) |
| AU (2) | AU6730598A (sh) |
| BR (1) | BR9808422B1 (sh) |
| CA (1) | CA2284802C (sh) |
| CO (1) | CO4940499A1 (sh) |
| CZ (1) | CZ293786B6 (sh) |
| DE (3) | DE69840816D1 (sh) |
| DK (2) | DK0975599T3 (sh) |
| EA (1) | EA002224B1 (sh) |
| EE (1) | EE04113B1 (sh) |
| ES (2) | ES2210757T3 (sh) |
| HK (1) | HK1023342A1 (sh) |
| HR (1) | HRP980157B1 (sh) |
| HU (1) | HU228230B1 (sh) |
| ID (1) | ID22901A (sh) |
| IL (1) | IL131918A (sh) |
| IS (2) | IS2346B (sh) |
| MA (1) | MA26476A1 (sh) |
| MY (1) | MY121316A (sh) |
| NO (1) | NO314726B1 (sh) |
| NZ (1) | NZ337797A (sh) |
| PE (1) | PE68399A1 (sh) |
| PL (1) | PL190860B1 (sh) |
| PT (2) | PT971898E (sh) |
| RS (1) | RS49869B (sh) |
| SI (1) | SI0975599T1 (sh) |
| TR (1) | TR199902330T2 (sh) |
| TW (1) | TW505635B (sh) |
| UY (1) | UY24933A1 (sh) |
| WO (2) | WO1998042675A1 (sh) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE254107T1 (de) * | 1997-03-25 | 2003-11-15 | Avera Pharmaceuticals Inc | Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker |
| US6911455B2 (en) | 1999-12-22 | 2005-06-28 | Smithkline Beecham Corporation | Methods for preparing pharmaceutical formulations |
| US6844904B2 (en) * | 2002-12-07 | 2005-01-18 | Cubic Corporation | Fast PDLC device |
| WO2005041960A2 (en) * | 2003-10-28 | 2005-05-12 | Cornell Research Foundation, Inc. | Neuromuscular blocking agents and antagonists thereof |
| US8148398B2 (en) | 2006-12-06 | 2012-04-03 | Cornell Research Foundation, Inc. | Intermediate duration neuromuscular blocking agents and antagonists thereof |
| AU2008222298A1 (en) | 2007-03-08 | 2008-09-12 | Chemagis Ltd. | (1R,1'R)-atracurium salts separation process |
| US20100087650A1 (en) * | 2007-03-26 | 2010-04-08 | Chemagis Ltd. | (1r,1'r)-atracurium salts separation process |
| CA2685491A1 (en) * | 2007-05-01 | 2008-11-06 | Chemagis Ltd. | Process for producing cisatracurium compounds and associated intermediates |
| CA2685488A1 (en) | 2007-05-01 | 2008-11-06 | Chemagis Ltd. | Novel isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates |
| CA2687157A1 (en) | 2007-06-18 | 2008-12-24 | Chemagis Ltd. | (1r,1'r)-atracurium salts separation process |
| US20100256381A1 (en) * | 2007-07-09 | 2010-10-07 | Chemagis Ltd. | Process for producing cisatracurium and associated intermediates |
| WO2009057086A1 (en) * | 2007-10-29 | 2009-05-07 | Chemagis Ltd. | Novel r,r'-atracurium salts |
| AU2009241211A1 (en) * | 2008-05-01 | 2009-11-05 | Chemagis Ltd. | Cisatracurium derivatives, preparation and uses thereof |
| US8592451B2 (en) | 2009-03-17 | 2013-11-26 | Cornell University | Reversible nondepolarizing neuromuscular blockade agents and methods for their use |
| US9220700B2 (en) | 2009-08-19 | 2015-12-29 | Cornell University | Cysteine for physiological injection |
| EP2867219B1 (en) * | 2012-06-29 | 2017-02-15 | Cornell University | Asymmetrical reversible neuromuscular blocking agents of ultra-short, short, or intermediate duration |
| CN103373959A (zh) * | 2013-06-14 | 2013-10-30 | 安徽省先锋制药有限公司 | 顺式苄基异喹啉类化合物的制备方法及其用途 |
| WO2014210369A2 (en) * | 2013-06-28 | 2014-12-31 | Cornell University | Reversal of cysteine-inactivated neuromuscular blocking drugs with combinations of reversal agents |
| CN108375644B (zh) * | 2016-12-07 | 2021-11-30 | 四川科瑞德制药股份有限公司 | 一种神经肌肉阻滞剂中间体的分析方法 |
| CN108938573B (zh) * | 2017-05-26 | 2021-08-10 | 四川科瑞德制药股份有限公司 | 一种神经肌肉阻滞剂组合物及其制备方法和用途 |
| CN110776481B (zh) * | 2018-07-24 | 2023-06-16 | 四川大学华西医院 | 一类双阳离子化合物及其制备方法和用途 |
| CN109776486A (zh) * | 2019-02-26 | 2019-05-21 | 武汉松石科技股份有限公司 | 一种硫酸亚丙酯的制备方法 |
| CN111662230A (zh) * | 2019-03-06 | 2020-09-15 | 四川道珍科技有限公司 | 一类苄基异喹啉化合物、制备方法和用途 |
| CN110117297A (zh) * | 2019-04-10 | 2019-08-13 | 珠海市赛纬电子材料股份有限公司 | 一种2-磷酸盐基硫酸丙烯酯的制备方法 |
| TW202128628A (zh) * | 2019-12-11 | 2021-08-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 神經肌肉阻滯劑及其製備方法 |
| CN111471013B (zh) * | 2020-05-26 | 2021-04-30 | 朗天药业(湖北)有限公司 | 一种米库氯铵及其注射液的制备方法 |
| CN111909089B (zh) * | 2020-08-14 | 2023-04-14 | 广东嘉博制药有限公司 | 一种米库氯铵对照品的制备方法 |
| CN114057642B (zh) * | 2021-12-10 | 2023-03-28 | 广东嘉博制药有限公司 | 一种米库氯铵中间体的合成方法 |
| CN115073373A (zh) * | 2022-07-08 | 2022-09-20 | 广东嘉博制药有限公司 | 一种不对称合成（r）-5’-甲氧基劳丹素的方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3004031A (en) * | 1958-07-03 | 1961-10-10 | Allen & Hauburys Ltd | Diquaternary salts of papaverino esters |
| AU506657B2 (en) * | 1975-12-10 | 1980-01-17 | Wellcome Foundation Limited, The | Isoquinoline derivatives |
| SE7808267L (sv) * | 1977-08-01 | 1979-02-02 | Massachusetts Gen Hospital | Neuromuskulert blockeringsmedel |
| US4701460A (en) * | 1980-12-17 | 1987-10-20 | Burroughs Wellcome Co. | Long duration neuromuscular blocking agents |
| JPS5899465A (ja) * | 1981-11-23 | 1983-06-13 | ザ・ウエルカム・フアウンデ−シヨン・リミテツド | イソキノリン誘導体 |
| GB8418303D0 (en) | 1984-07-18 | 1984-08-22 | Wellcome Found | Compounds |
| BG41897A1 (en) | 1985-07-19 | 1987-09-15 | Ivanov | Dichlormethylate of n, n'- 4, 10- dioxa- 3, 11- bis- tetrahydropapaverine and method for its preparation |
| GB9015473D0 (en) | 1990-07-13 | 1990-08-29 | Wellcome Found | Neuromuscular blocking agents |
| JPH04112016A (ja) * | 1990-09-03 | 1992-04-14 | Fuji Electric Co Ltd | トランスファ成形金型用プランジャ及びトランスファ成形装置 |
| US5240939A (en) * | 1991-10-31 | 1993-08-31 | Anaquest, Inc. | Nitrogen bridge tetrahydroisoquinolines |
| ATE254107T1 (de) * | 1997-03-25 | 2003-11-15 | Avera Pharmaceuticals Inc | Substituierte isochinoline als ultra kurz wirkende neuromuskuläre blocker |
-
1998
- 1998-03-23 AT AT98922626T patent/ATE254107T1/de active
- 1998-03-23 PE PE1998000209A patent/PE68399A1/es not_active Application Discontinuation
- 1998-03-23 TR TR1999/02330T patent/TR199902330T2/xx unknown
- 1998-03-23 BR BRPI9808422-4A patent/BR9808422B1/pt not_active IP Right Cessation
- 1998-03-23 AP APAP/P/1999/001658A patent/AP1797A/en active
- 1998-03-23 KR KR1019997008687A patent/KR100554601B1/ko not_active IP Right Cessation
- 1998-03-23 PT PT98912494T patent/PT971898E/pt unknown
- 1998-03-23 AT AT03020565T patent/ATE430734T1/de not_active IP Right Cessation
- 1998-03-23 CA CA002284802A patent/CA2284802C/en not_active Expired - Fee Related
- 1998-03-23 JP JP54323298A patent/JP4112015B2/ja not_active Expired - Fee Related
- 1998-03-23 PT PT98922626T patent/PT975599E/pt unknown
- 1998-03-23 SI SI9830593T patent/SI0975599T1/xx unknown
- 1998-03-23 EP EP05001475A patent/EP1526130A1/en not_active Withdrawn
- 1998-03-23 DE DE69840816T patent/DE69840816D1/de not_active Expired - Lifetime
- 1998-03-23 EP EP98922626A patent/EP0975599B1/en not_active Expired - Lifetime
- 1998-03-23 IL IL13191898A patent/IL131918A/xx not_active IP Right Cessation
- 1998-03-23 ES ES98922626T patent/ES2210757T3/es not_active Expired - Lifetime
- 1998-03-23 CN CNB988053004A patent/CN1203061C/zh not_active Expired - Fee Related
- 1998-03-23 RS YUP-483/99A patent/RS49869B/sr unknown
- 1998-03-23 CZ CZ19993404A patent/CZ293786B6/cs not_active IP Right Cessation
- 1998-03-23 EP EP98912494A patent/EP0971898B1/en not_active Expired - Lifetime
- 1998-03-23 AU AU67305/98A patent/AU6730598A/en not_active Abandoned
- 1998-03-23 WO PCT/EP1998/001652 patent/WO1998042675A1/en active IP Right Grant
- 1998-03-23 MY MYPI98001252A patent/MY121316A/en unknown
- 1998-03-23 WO PCT/EP1998/001651 patent/WO1998042674A1/en not_active Application Discontinuation
- 1998-03-23 DK DK98922626T patent/DK0975599T3/da active
- 1998-03-23 ES ES98912494T patent/ES2242275T3/es not_active Expired - Lifetime
- 1998-03-23 MA MA25006A patent/MA26476A1/fr unknown
- 1998-03-23 JP JP54323398A patent/JP4112016B2/ja not_active Expired - Fee Related
- 1998-03-23 PL PL335885A patent/PL190860B1/pl not_active IP Right Cessation
- 1998-03-23 HU HU0001556A patent/HU228230B1/hu not_active IP Right Cessation
- 1998-03-23 EA EA199900756A patent/EA002224B1/ru not_active IP Right Cessation
- 1998-03-23 EP EP03020565A patent/EP1380573B1/en not_active Expired - Lifetime
- 1998-03-23 KR KR1020057019867A patent/KR100578443B1/ko not_active IP Right Cessation
- 1998-03-23 ID IDW991103A patent/ID22901A/id unknown
- 1998-03-23 DE DE69819703T patent/DE69819703T2/de not_active Expired - Lifetime
- 1998-03-23 US US09/381,721 patent/US6177445B1/en not_active Expired - Fee Related
- 1998-03-23 US US09/381,719 patent/US6187789B1/en not_active Expired - Lifetime
- 1998-03-23 EE EEP199900424A patent/EE04113B1/xx not_active IP Right Cessation
- 1998-03-23 AT AT98912494T patent/ATE295351T1/de not_active IP Right Cessation
- 1998-03-23 DE DE69830157T patent/DE69830157T2/de not_active Expired - Lifetime
- 1998-03-23 AU AU75210/98A patent/AU745382B2/en not_active Ceased
- 1998-03-23 NZ NZ337797A patent/NZ337797A/xx not_active IP Right Cessation
- 1998-03-23 DK DK98912494T patent/DK0971898T3/da active
- 1998-03-24 UY UY24933A patent/UY24933A1/es not_active IP Right Cessation
- 1998-03-24 HR HR980157A patent/HRP980157B1/xx not_active IP Right Cessation
- 1998-03-24 AR ARP980101340A patent/AR012156A1/es active IP Right Grant
- 1998-03-25 CO CO98016617A patent/CO4940499A1/es unknown
- 1998-04-29 TW TW087106631A patent/TW505635B/zh not_active IP Right Cessation
-
1999
- 1999-09-17 IS IS5185A patent/IS2346B/is unknown
- 1999-09-24 NO NO19994680A patent/NO314726B1/no not_active IP Right Cessation
-
2000
- 2000-04-25 HK HK00102447A patent/HK1023342A1/xx not_active IP Right Cessation
-
2007
- 2007-09-25 JP JP2007247928A patent/JP2008019272A/ja active Pending
-
2008
- 2008-03-03 IS IS8717A patent/IS8717A/is unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP1797A (en) | Substituted isoquinolines as ultra short acting neuromuscular blockers. | |
| AU574481B2 (en) | Bis-isoquinolium derivatives | |
| MY102986A (en) | Benzo (5,6) cycloheptapyridines, compositions and methods of use | |
| ZA9610315B (en) | Naphthyl-substituted benzimidazole derivates as anti-coagulants | |
| AU5624699A (en) | Use of 5ht-6 antagonists | |
| MXPA00009593A (es) | Compuestos de eter aminociclohexilico y sus usos. | |
| CA2210044A1 (en) | 4-hydroxy-piperidine derivatives | |
| AU7493794A (en) | Hydroisoquinoline derivatives | |
| CA2020474A1 (en) | Antiinflammatory and/or antiallergic composition | |
| CA2014885A1 (en) | 6,11-dihydro-5h-pyrido[2,3-b][1,5]benzodiazepin-5-ones and thiones and their use in the prevention or treatment of aids | |
| MY118244A (en) | Alfa-amino acid amides, preparation thereof and the therapeutical use thereof | |
| CA2289017A1 (en) | The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer | |
| DE3464603D1 (en) | 2-anilino-1,6-dihydro-6-oxo-5-pyrimidinecarboxylic acid derivatives, processes for the preparation thereof, and antiallergic agent containing the same | |
| UA41329C2 (uk) | Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, похідні 3-фенілсульфоніл-3,7-діазабіцикло[3,3,1]нонану та лікарський засіб для лікування аритмії | |
| CA2204204A1 (en) | Carbohydrate derivatives | |
| ES2102295A1 (es) | Nuevos compuestos derivados de la n-benzoilmetil-piperidina. | |
| IE812033L (en) | Quinolones | |
| IL112344A (en) | Pharmaceutical compositions comprising 7, 9, 9-trisubstituted- 3-benzoyl-3, 7-diazabicyclo £3.3.1| nonanes for the treatment of cardiac arrhythmias | |
| MX9701606A (es) | Terapia de combinacion para evitar la perdida osea-progesterona y agonistas de estrogeno. | |
| MY106564A (en) | Sulfur-substituted mevinic acid derivatives. | |
| NZ511411A (en) | Benzisoxazoles and phenones as alpha2-antagonists | |
| ES2013391A6 (es) | Procedimiento para la preparacion de derivados acetilenicos y alenicos de 2-aminometil -5-metoxiindoles. | |
| PT83307B (en) | Spirobenzofuran-2 (3h),1'-cycloheptanes a process and interme diates for their preparation and their use as medicaments | |
| ES8202811A1 (es) | Un procedimiento para la preparacion de derivados de benzo (1,4) dioxina | |
| NZ513033A (en) | Dry skin remedies |